Tiny polymer capsules keep a surprising number of daily technologies on track. They guide medicines through the bloodstream, lock fragrant oils inside perfumes, and hold conductive inks steady while a three-dimensional printer lays down flexible circuits. Each capsule is barely a few hundred nanometers wide, about one two-hundredth the thickness of a human hair, yet its job is critical: surround a payload, shield it from heat and rough handling, then release it at the right moment.
Most of today’s capsules have walls made from tangled polymer chains. That disorder leaves soft spots. Heat from processing, the shear of a pump, or months on a shelf can open tiny pathways that let the payload seep out or the shell crack.
What has been missing is a hollow capsule with a thin, strong, uniform wall. That solution began taking shape in 2016 when Christopher Li, PhD, professor of materials science and engineering at Drexel University, examined an electron-microscope image of particles made from poly L lactic acid, or PLLA. His team had cooled tiny PLLA droplets in water. Instead of forming flat crystal plates, the polymer chains curved all the way around each droplet and sealed a hollow center. He called the new particles “crystalsomes,” joining “crystal” with “liposome” to signal a crystal-ordered shell wrapped around an empty core.
“We designed crystalsomes from the start,” Li said. “Our goal was to control polymer crystallization on curved surfaces so we could study the fundamentals and create a sturdier alternative to liposomes and polymersomes.”
Mechanical tests later showed that a crystalsome shell is hundreds of times stiffer than the soft vesicles common in drug delivery, yet the seamless curve lets it bend without cracking.
Two years later, working with Hao Cheng, PhD, associate professor of materials science and engineering, Li’s group proved that crystalsomes can also stay in the body longer than most carriers. They built a two-part polymer chain, with one segment forming the inner crystalline shell and an outer segment of polyethylene glycol, or PEG, coating the surface.
In the bloodstream, thousands of proteins normally latch onto foreign particles, marking them for removal by the immune system. PEG creates a flexible, water-loving layer that offers those proteins nothing to grab. With the flags missing, immune cells ignore the capsule and it circulates far longer. Loaded with a fluorescent dye, PEG-coated crystalsomes stayed in a mouse’s bloodstream for a full day, much longer than most comparable carriers.
Early crystalsomes were limited to the diameters that their emulsion droplets allowed their emulsion droplets allowed, so Li’s team worked with Bin Zhao, PhD, a chemistry professor at the University of Tennessee, Knoxville, to search for a way to let the polymer choose its own curvature. In 2020 they landed on bottlebrush molecules that look like spines lined with bristles. As those bristles (the crystallizing side chains) packed closer together, they forced the growing layer to arch into a hollow sphere, all without a droplet template.
Freed from the constraints of emulsion size, the researchers began adding new ingredients. Metallic cores, fluorescent dyes, and antibody-friendly chemical hooks can all be incorporated into the capsule while it forms, creating hybrid shells with built-in functions.
A three-year grant from the National Science Foundation, worth a little more than $1 million, is now letting Li’s team film crystalsome growth frame by frame. Rapid X-ray pulses and cryo-electron snapshots follow each step from the first crystal seed to the final snap that closes the shell.
“This NSF grant lets us dig into the formation mechanism, expand the crystalsome family with new functional groups, tighten the size distribution, and learn how to scale up the process using greener solvents,” Li said.
Two recent papers mark the newest turns in the story. In January, Li’s group published a review in the journal Polymer that maps how curved interfaces, bottlebrush crowding, and even metal nanoparticles can guide single-crystal shells of many shapes and chemistries. Soon after, the team showed that adjusting the chain ends of short PLLA strands can make individual crystal sheets curl into scrolls, creating tiny rolled structures that open another path to three-dimensional shapes.
Finding effective ways to scale up production remains a priority. Milligram batches cool evenly and produce flawless spheres, but kilogram reactors swirl with hot and cold zones that can plant defects. Residual surfactants must also be removed before any capsule reaches people.
“Strength is valuable only if the body can break the material down in the end,” Li noted. “We are tuning the chemistry so the capsules survive the journey yet eventually fall apart into harmless fragments.”
Nine years after that first shimmering bubble appeared on a Drexel monitor, crystalsomes have moved from carefully designed curiosity to versatile engineering tool. The newest studies show a field shifting from asking whether such shells can be made to deciding exactly how to tailor them. If Li’s cameras capture the growth pathway as clearly as he expects, tomorrow’s medicines, printable circuits, and heat-resistant coatings may all begin life as tiny, perfectly curved crystals grown rather than molded.
